TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 148 filers reported holding TG THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $41,993,000 | -69.2% | 2,210,145 | -46.1% | 0.74% | -60.8% |
Q3 2021 | $136,392,000 | +5.2% | 4,098,332 | +22.6% | 1.89% | -9.2% |
Q2 2021 | $129,665,000 | -42.0% | 3,342,743 | -27.9% | 2.08% | -38.2% |
Q1 2021 | $223,462,000 | -50.5% | 4,636,146 | -46.6% | 3.37% | -46.6% |
Q4 2020 | $451,818,000 | +91.3% | 8,685,471 | -1.6% | 6.32% | +46.2% |
Q3 2020 | $236,180,000 | -5.2% | 8,825,849 | -31.0% | 4.32% | -11.0% |
Q2 2020 | $249,119,000 | +143.7% | 12,788,457 | +23.1% | 4.85% | +50.3% |
Q1 2020 | $102,212,000 | -6.8% | 10,387,411 | +5.1% | 3.23% | -2.9% |
Q4 2019 | $109,672,000 | +183.9% | 9,880,323 | +43.6% | 3.33% | +44.5% |
Q3 2019 | $38,633,000 | -35.1% | 6,880,323 | 0.0% | 2.30% | -27.9% |
Q2 2019 | $59,515,000 | -9.7% | 6,880,323 | -16.1% | 3.20% | +12.4% |
Q1 2019 | $65,915,000 | +96.1% | 8,198,337 | 0.0% | 2.84% | +45.2% |
Q4 2018 | $33,613,000 | -26.8% | 8,198,337 | 0.0% | 1.96% | -20.3% |
Q3 2018 | $45,911,000 | -18.4% | 8,198,337 | +91.6% | 2.45% | -32.8% |
Q2 2018 | $56,266,000 | +60.3% | 4,278,796 | +73.1% | 3.65% | +35.8% |
Q1 2018 | $35,107,000 | +323.2% | 2,472,344 | +253.2% | 2.69% | +259.1% |
Q3 2017 | $8,295,000 | +17.9% | 700,000 | 0.0% | 0.75% | -7.2% |
Q2 2017 | $7,035,000 | -13.7% | 700,000 | 0.0% | 0.81% | -19.3% |
Q1 2017 | $8,155,000 | +74.6% | 700,000 | -30.3% | 1.00% | +51.1% |
Q4 2016 | $4,670,000 | -87.0% | 1,004,314 | -78.3% | 0.66% | -82.1% |
Q3 2016 | $35,845,000 | +30.5% | 4,631,114 | +2.2% | 3.70% | -2.7% |
Q2 2016 | $27,462,000 | -28.9% | 4,531,714 | 0.0% | 3.80% | -23.0% |
Q1 2016 | $38,610,000 | +15.0% | 4,531,714 | +61.1% | 4.94% | +48.6% |
Q4 2015 | $33,568,000 | +6.6% | 2,813,779 | -9.9% | 3.32% | -26.6% |
Q3 2015 | $31,495,000 | -42.5% | 3,124,480 | -5.4% | 4.52% | -17.9% |
Q2 2015 | $54,784,000 | +13.2% | 3,302,213 | +5.7% | 5.51% | +14.7% |
Q1 2015 | $48,377,000 | -8.8% | 3,125,149 | -6.7% | 4.80% | -15.8% |
Q4 2014 | $53,071,000 | +140.8% | 3,350,449 | +62.2% | 5.70% | +119.0% |
Q3 2014 | $22,040,000 | +628.8% | 2,065,571 | +244.3% | 2.60% | +724.1% |
Q3 2013 | $3,024,000 | – | 600,000 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
Antara Capital LP | 900,000 | $3,825,000 | 0.16% |